ATAI Life Sciences is preparing to add three new drug development partners as it builds the premier R&D platform in the psychedelics space.
IntelGenx Enters into Feasibility Agreement with ATAI Life Sciences to Develop Pharmaceutical-Grade Polymeric Film-Based Psychedelics
IntelGenX enters into agreement with ATAI Life Sciences to develop novel formulations of pharmaceutical-grade psychedelics.
PSYC Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights
Global Trac Solutions is developing a media partnership with Microdose.
Mydecine™ Launches World's First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise
Mydecine is ready to start supplying GMP-quality psilocybin to advance psychedelics R&D.
Psychedelic Drugs: Powerful Medicine, Life-Changing Results
Psychedelic drug therapies continue to win over new supporters. But the clock is ticking with our Mental Health Crisis...
Field Trip Psychedelics Inc. Expands Stateside With Psychedelic-Enhanced Psychotherapy Clinic in New York City
Field Trip adds a ketamine-assisted psychotherapy clinic to its operations.
New Psychedelic Research Nonprofit Teams with Johns Hopkins University for Real-World Study on Use of Psilocybin Mushrooms
Unlimited Science, a psychedelics non-profit R&D organization, is collaborating with Johns Hopkins.
Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results
MindMed reported a net loss of $5.8 million for first 6 months of 2020, has USD $24 million in cash.
Psychedelics and Cannabis: Part 2, Industry Overlap
Among publicly listed companies in the psychedelics space, most are psychedelics-cannabis hybrids. It actually makes a lot of sense.
MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President
MindMed's new President will be expanding the company's R&D footprint in Europe and leading Project Lucy.
MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President
MindMed's new President will be expanding the company's R&D footprint in Europe and leading Project Lucy.
GHP Noetic Science-Psychedelic Pharma Inc. Announces Closing of Initial Public Offering
A new psychedelics company began trading August 11th.
